Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Agenda
- Gastroparesis: definition
- Diabetic gastropathy
- Gastroparesis: suggestive symptoms
- Magnitude
- From the gastroparesis consortium (GpCRC)
- Diabetes and gastroparesis
- Gastroparesis physiology from GpCRC
- UGI neuropathic condition
- Causes of gastroparesis
- Molecular pathophysiology from GcCRC
- Molecular physiology from GcCRC
- Functional parts of the stomach
- Pathophysiology of gastroparesis
- Factors that slow gastric emptying
- Range of gastric dysmotility
- Gastroparesis: evaluation
- Gastric scintigraphy
- Gastric emptying scans: advantages
- Gastric emptying scans: disadvantages
- Wireless motility capsule: measure of function
- Wireless motility capsule: gastric emptying
- Other emptying tests
- Current treatment of gastroparesis
- Medications that slow gastric emptying
- Dietary recommendations for gastroparesis
- Three-step dietary treatment
- Nutritional status
- Prokinetic therapies
- Metoclopramide
- Metoclopramide side effects
- Metoclopramide and tardive dyskinesia
- Erythromycin
- Domperidone
- Domperidone: gastroparesis
- Cisapride
- Summary of prokinetic agents
- Antiemetic therapies
- Abdominal pain in gastroparesis
- TCAs and gastroparesis: NORIG
- NORIG
- Botulinum toxin
- Studies on Botox and gastroparesis
- GPOEM for gastroparesis
- Surgery and gastroparesis
- Gastric stimulation (1)
- Gastric stimulation: MOA
- Gastric stimulation (2)
- Gastric stimulation (3)
- Future drugs
- Behavioral therapy and psychopharmacology
- Potential non-drug treatments
Topics Covered
- Symptoms, definition and epidemiology of gastroparesis
- Gastroparesis consortium
- Diabetes and gastroparesis
- Causes of gastroparesis
- Molecular pathophysiology
- Factors that slow gastric emptying
- Range of gastric dysmotility
- Evaluation of gastroparesis
- Gastric emptying scans and tests
- Medications that slow gastric emptying
- Dietary recommendations
- Prokinetic therapies such as Metoclopramide and Erythromycin
- Antiemetic therapies
- Abdominal pain in gastroparesis
- NORIG
- Additional treatments such as Botox and gastric stimulation
- Future drugs
- Non-drug treatments
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Kuo, B. (2020, April 29). Disorders of gastric function: gastroparesis and functional dyspepsia 1 [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/MDEP2927.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial matters to disclose.
Disorders of gastric function: gastroparesis and functional dyspepsia 1
Published on April 29, 2020
39 min
A selection of talks on Gastroenterology & Nephrology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. My name is Dr. Braden Kuo.
I'm a gastroenterologist and physician at
the Gastrointestinal Unit at Massachusetts General Hospital and Harvard Medical School.
Today, I'll be talking about disorders of gastric function,
specifically gastroparesis and functional dyspepsia.
0:18
Today, as part of the agenda,
we'll be talking about the symptoms, definitions,
and epidemiology, reviewing a little bit about
the pathophysiology and also the treatment paradigms.
0:30
Gastroparesis as a definition is delayed gastric emptying in
the absence of a fixed mechanical obstruction of the pylorus or small intestine.
0:39
In the bigger complex,
one can think about diabetic gastropathy,
which is a symptom complex of functional, contractile, electrical,
and sensory dysfunction of the stomach associated with diabetes.
Patients can have pain or discomfort,
rapid or even delayed emptying.
0:56
Some suggestive symptoms include early satiety, anorexia, food avoidance,
bloating and fullness, heartburn, nausea,
abdominal pain or discomfort,
weight loss, postprandial vomiting.
1:11
Fifty percent of patients in
general practice clinics or in gastroenterology clinics may have
motility disorders and 76 percent of patients in
a diabetic clinic had chronic or recurrent symptoms consistent with gastroparesis,
which ultimately may complicate the glucose regulation.
Fifty percent of patients with non-ulcer dyspepsia or
functional dyspepsia have delayed gastric emptying with impaired antral motility.
1:35
From the gastroparesis consortium,
the burden of illness,
impaired quality life, and co-morbidities
associated with gastroparesis are highly significant.
Majority, over two-thirds of the patients do not improve over time and obesity is common
amongst patients with gastroparesis and it's associated
with differences in clinical phenotype with a worse outcome.
Post-infectious gastroparesis is suspected in a significant proportion of patients.
Hide